ANXA3 as a novel biomarker for sepsis diagnosis: Evidence from integrative WGCNA analysis

Jing-Xiang Zhang, Xin-Hao Xing, Ren-Yi Lu, Meng-Xiao Liu, Wei-Heng Xu, Hao-Cheng Zhang, Qing-Jie Zhao, Yan Wang

Open source

DOI
10.1016/j.heliyon.2024.e38608
Published
2024-10
Container
Heliyon
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.heliyon.2024.e38608,
  title = {ANXA3 as a novel biomarker for sepsis diagnosis: Evidence from integrative WGCNA analysis},
  author = {Jing-Xiang Zhang and Xin-Hao Xing and Ren-Yi Lu and Meng-Xiao Liu and Wei-Heng Xu and Hao-Cheng Zhang and Qing-Jie Zhao and Yan Wang},
  year = {2024},
  journal = {Heliyon},
  doi = {10.1016/j.heliyon.2024.e38608},
  url = {https://doi.org/10.1016/j.heliyon.2024.e38608}
}

RIS

TY  - JOUR
TI  - ANXA3 as a novel biomarker for sepsis diagnosis: Evidence from integrative WGCNA analysis
AU  - Jing-Xiang Zhang
AU  - Xin-Hao Xing
AU  - Ren-Yi Lu
AU  - Meng-Xiao Liu
AU  - Wei-Heng Xu
AU  - Hao-Cheng Zhang
AU  - Qing-Jie Zhao
AU  - Yan Wang
PY  - 2024
JO  - Heliyon
DO  - 10.1016/j.heliyon.2024.e38608
UR  - https://doi.org/10.1016/j.heliyon.2024.e38608
ER  - 

APA

Zhang, J., Xing, X., Lu, R., Liu, M., Xu, W., Zhang, H., Zhao, Q., & Wang, Y. (2024). ANXA3 as a novel biomarker for sepsis diagnosis: Evidence from integrative WGCNA analysis. Heliyon. https://doi.org/10.1016/j.heliyon.2024.e38608

Source records